General Information of the Compound
Compound ID
CP0405774
Compound Name
(R)-9-butyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino-[2,1-a]isoindol-6(2H)-one
    Show/Hide
Structure
Formula
C16H19F3N2O
Molecular Weight
312.335
Canonical SMILES
CCCCc1cc2[C@@H]3CNCCN3C(=O)c2c(c1)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C16H19F3N2O/c1-2-3-4-10-7-11-13-9-20-5-6-21(13)15(22)14(11)12(8-10)16(17,18)19/h7-8,13,20H,2-6,9H2,1H3/t13-/m0/s1
    Show/Hide
InChIKey
UDGYHMBUODQQEI-ZDUSSCGKSA-N
Physicochemical Property
logP
3.1481
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
32.34
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11187156
ChEMBL ID
CHEMBL373483
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
2
Ki = 627 nM
   TI
   LI
   LO
   TS
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
2
Ki = 220 nM
   TI
   LI
   LO
   TS
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 363 nM
   TI
   LI
   LO
   TS
2
Ki = 57 nM
   TI
   LI
   LO
   TS